AI Terminal
Ambu
Regulatory Filings • Mar 18, 2020
3353_iss_2020-03-18_19795035-46b7-47eb-aa00-12cdaa1391ea.html
Regulatory Filings
Open in ViewerOpens in native device viewer
Ambu A/S: Ambu’s production exempt from Malaysian movement control order
Ambu A/S: Ambu’s production exempt from Malaysian movement control order
The Malaysian authorities have granted Ambu – as a manufacturer of medical devices – exemption from the two-week movement control order that has been declared with effect from 18 March, 2020. The nationwide movement control order is an initiative to counter the spread of Covid-19 in Malaysia.
“Our role is to keep supplying hospitals around the globe with devices that help save lives and improve patient care. With the current pressure on national healthcare systems, we do our utmost to make sure that we can keep producing and delivering supplies to hospitals. Therefore, it is positive that the Malaysian authorities recognize the role we play in supporting healthcare facilities,” says Juan Jose Gonzalez, CEO of Ambu.
**
Contacts**
Investors
Michael Højgaard, CFO, tel. +45 4030 4349, email: [email protected]
Nicolai Thomsen, Investor Relations Manager, tel. +45 2620 8047, email: [email protected]
Media
Mikkel Trier Wagner, Director Corporate Communications, tel. +45 4191 0830, email: [email protected]
Attachment